Yang, Chaozhe
Harafuji, Naoe
O’Connor, Amber K.
Kesterson, Robert A.
Watts, Jacob A.
Majmundar, Amar J.
Braun, Daniela A.
Lek, Monkol
Laricchia, Kristen M.
Fathy, Hanan M.
Mane, Shrikant
Shril, Shirlee
Hildebrandt, Friedhelm
Guay-Woodford, Lisa M.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK074038, T32 DK 007726, DK 076683 13)
National Cancer Institute (P30 CA13148)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR048311)
Harvard Stem Cell Institute (2017 Postdoctoral Fellowship)
American Society of Nephrology (PKD Foundation Grantham Fellowship)
German Research Foundation (404527522)
National Institutes of Health (UM1 HG008900)
National Human Genome Research Institute (R01 HG009141, UM1 HG006504)
Article History
Received: 22 March 2021
Accepted: 22 July 2021
First Online: 14 September 2021
Competing interests
: F.H. is a co-founder of Goldfinch Biopharma Inc. All other authors declare no competing interests.